Efficacy and safety of PXT3003 in patients with Charcot-Marie-Tooth type 1A (CMT1A): results of PLEO-CMT an International Pivotal Phase 3 trial. For the PLEO CMT Investigators
EUROPEAN JOURNAL OF NEUROLOGY（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要